Neurology:卒中前认知损害或不影响缺血性卒中患者rtPA溶栓治疗

2014-05-19 cath 编译 医学论坛网

一项多国联合研究表明,卒中前认知损害(PSCI)的缺血性卒中患者如果符合条件,应该接受重组组织型纤溶酶原激活剂(rtPA)治疗;但不能扩展到严重认知损害或严重卒中患者。该研究为存在PSCI的急性缺血性卒中患者接受IV rtPA 治疗可改善其预后提供了IV级证据。相关论文5月14日在线发表于《神经病学》(Neurology)杂志。 该多中心前瞻性观察研究名为“OPHELIE-COG”,旨在探讨接受

一项多国联合研究表明,卒中前认知损害(PSCI)的缺血性卒中患者如果符合条件,应该接受重组组织型纤溶酶原激活剂(rtPA)治疗;但不能扩展到严重认知损害或严重卒中患者。该研究为存在PSCI的急性缺血性卒中患者接受IV rtPA 治疗可改善其预后提供了IV级证据。相关论文5月14日在线发表于《神经病学》(Neurology)杂志。

该多中心前瞻性观察研究名为“OPHELIE-COG”,旨在探讨接受rtPA治疗的卒中患者PSCI对其转归的影响。共纳入205例接受静脉注射(IV)rtPA治疗的法国和日本缺血性卒中患者。在老年人群中通过认知问卷简短版调查评估先前的认知状态。以平均分数>3定义为PSCI。主要终点为3个月后良好转归[改良Rankin量表(mRS)0–1分]。次要终点为3个月后症状性颅内出血(sICH)、mRS评分0–2和死亡率。

结果显示,62例患者(30.2%)符合PSCI标准,他们年龄偏大11岁。虽然这些患者3个月后更多的发生sICH,且较少能独立活动,但在校正年龄、基线其NIH卒中量表评分和发病至进针时间后,患者的任一终点无差异;sICH、mRS 0–1、mRS 0–2和死亡的比值比(OR)分别为2.78、0.82、0.62和0.40。汇集分析显示,PSCI与任何终点均无相关性。

原始出处:


Murao K1, Leys D2, Jacquin A1, Kitazono T1, Bordet R1, Béjot Y1, Kimura K1, Godefroy O1, Wakisaka Y1, Moulin S1, Ago T1, Sibon I1, Bombois S1, Mas JL1, Hénon H1, Pasquier F1, Giroud M1, Cordonnier C1, Okada Y1; On behalf of the OPHELIE-COG investigators.Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.Neurology. 2014 May 14. pii: 10.1212/WNL.0000000000000493. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-12-01 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-07-07 循证小兵
  6. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1720023, encodeId=7c931e20023cd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Nov 26 15:24:00 CST 2014, time=2014-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999419, encodeId=907c1999419d9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 01 08:24:00 CST 2014, time=2014-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935455, encodeId=94ad1935455e9, content=<a href='/topic/show?id=9f2515e29b1' target=_blank style='color:#2F92EE;'>#rtPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15729, encryptionId=9f2515e29b1, topicName=rtPA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Jun 11 19:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010321, encodeId=d7f620103218f, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Wed Jun 11 14:24:00 CST 2014, time=2014-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715685, encodeId=8bc31e156850f, content=<a href='/topic/show?id=8d0f1e691b5' target=_blank style='color:#2F92EE;'>#tPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17691, encryptionId=8d0f1e691b5, topicName=tPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2632003894, createdName=循证小兵, createdTime=Mon Jul 07 23:24:00 CST 2014, time=2014-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795812, encodeId=e7221e95812af, content=<a href='/topic/show?id=40511e692c9' target=_blank style='color:#2F92EE;'>#tPA溶栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17692, encryptionId=40511e692c9, topicName=tPA溶栓)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 31 12:24:00 CST 2014, time=2014-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805988, encodeId=404c180598826, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue May 20 17:24:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892611, encodeId=23c9189261160, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Apr 14 10:24:00 CST 2015, time=2015-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418528, encodeId=8634141852802, content=<a href='/topic/show?id=b88266482f7' target=_blank style='color:#2F92EE;'>#溶栓治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66482, encryptionId=b88266482f7, topicName=溶栓治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00673387794, createdName=lqvr, createdTime=Wed May 21 04:24:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-05-21 lqvr

相关资讯

Lancet:警惕短暂性脑缺血发作所引发的卒中

由血栓短暂性阻断脑血流所致的短暂性脑缺血发作(TIA),在英国每年的初发患者达46000人。因其结局最终会发生戏剧性的好转,患者经常会忽略其症状,认为其是由于其他疾病或老龄所致。然而,10%的TIA患者在发病后的7天内会继续进展而发生卒中。 尽管英国全国性的运动已增加了对与卒中症状的意识,但公众对于TIA症状以及立即就诊的重要性的意识仍然很弱。在一项由卒中协会(英国一个慈善机构)进行的调查中

2014 AHA/ASA卒中二级预防指南发布及专家解析

5月1日,美国心脏协会/美国卒中协会(AHA/ASA)公布了最新卒中二级预防指南。新指南继续强调血压、胆固醇、体重和运动的重要性,并包含了一些重要的新推荐。其中包括:对卒中和短暂性脑缺血发作(TIA)幸存者筛查糖尿病和肥胖。 对睡眠呼吸暂停进行筛查是合理的。 进行营养评估并建议患者遵循地中海饮食是合理的。 对有不明原因卒中的患者长期监测心房颤动(房颤)。 在特定情况下使用新

Lancet Neurol:卒中后精神障碍诊治临床综述

导读:全球每年大约有1600万新发卒中患者,其中约有570万人死亡,其他500万人遗留残疾。卒中后精神障碍十分常见,对患者及其家属造成巨大的痛苦和负担,但尚未得到医疗专业人士的重视,患者的治疗需求也未得到满足。在该篇综述中,研究者关注卒中后最常见的非认知功能性的神经精神症状——如抑郁,焦虑,情绪不稳以及淡漠。研究者也讨论了卒中后疲劳,人格改变,重度精神病,躁狂等。对于每一种神经精神障碍,均讨论

Stroke:医院策略影响急性缺血性脑卒中预后

静脉应用组织型纤溶酶原激活剂 (tPA), 是目前改善急性缺血性脑卒中预后最有效的治疗措施。但是,tPA 的效益具有高度时间依赖性。对于典型的大血管缺血性脑卒中,每一分钟的治疗延迟,就会导致约200万的神经元死亡。已有报告显示,采取适当的医院策略可以缩短入院到用药的时间,从而改善急性缺血性脑卒中的预后。 然而,医院使用这些策略的程度如何,以及医院策略与入院到用药的时间之间存在怎样的关系尚未得到很